El director ejecutivo de ONUSIDA, Michel Sidibé, visitó Mauricio, donde desde 2006 se están desarrollando programas de reducción de daños para rebajar el contagio de infecciones de transmisión sanguínea entre las personas que se inyectan drogas, tanto dentro como fuera de prisión. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas. 


In 2006, the Government of Mauritius started harm reduction programmes—needle exchange programmes and opioid substitution therapy (methadone)—to reduce the transmission of blood-borne infections among people who inject drugs both inside and outside prison. Government figures from 2012 show that more than 5 400 people were enrolled on opioid substitution therapy, and theGlobal AIDS response progress report for Mauritius for 2012 shows that HIV transmission through injecting drug use in Mauritius declined from 73% in 2010 to 68% in 2011.

During an official visit to Mauritius, UNAIDS Executive Director Michel Sidibé visited the Central Prison in Beau-Bassin, Mauritius’s largest prison, to learn about its opioid substitution programme, which allows inmates to continue receiving a daily dose of methadone while imprisoned.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert